Paper Details

  1. Home
  2. Paper Details

[Pharmacovigilance update].

Author: BiollazJ, BuclinT, LivioF

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This review discusses pharmacovigilance updates on several medications, including rosiglitazone, sibutramine, H1N1 vaccines, paroxetine, serotoninergic antidepressants, oral combined contraceptives containing drospirenone, saquinavir, rivastigmine, lamotrigine, and proton pump inhibitors.
Paper Details　
Original Abstract of the Article :
Main pharmacovigilance updates are reviewed. Rosiglitazone and sibutramine have been suspended due to cardiovascular risks. The safety profile of H1N1 vaccines is similar to the established profile of seasonal influenza vaccines. Paroxetine reduces the benefit of tamoxifen. The use of serotoninergic...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/21309181

データ提供：米国国立医学図書館（NLM）

Pharmacovigilance Updates: Ensuring Drug Safety

This article provides an overview of important pharmacovigilance updates, highlighting the ongoing efforts to monitor and ensure the safety of medications. The article discusses several key updates, including the suspension of rosiglitazone and sibutramine due to cardiovascular risks, the safety profile of H1N1 vaccines, and the potential interactions between paroxetine and tamoxifen. These updates demonstrate the dynamic nature of drug safety research, highlighting the importance of ongoing vigilance to ensure patient safety.

Ensuring Patient Safety: A Constant Vigilance

The pharmacovigilance updates discussed in this article underscore the importance of continuous monitoring and research to ensure the safety of medications. These updates highlight the importance of informed decision-making and the value of open communication between healthcare providers and patients regarding potential risks and benefits of medications.

Staying Informed About Medication Safety

It's crucial for patients to stay informed about potential risks and benefits of medications. Staying up-to-date on pharmacovigilance updates and discussing any concerns with your healthcare provider is essential for making informed decisions about your health.

Dr.Camel's Conclusion

Just as a camel carefully navigates the ever-changing desert landscape, pharmacovigilance professionals diligently monitor the ever-evolving landscape of medication safety. These updates serve as a reminder of the importance of staying informed and making informed decisions about our health.

Date :
  1. Date Completed 2011-03-29
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

21309181

DOI: Digital Object Identifier

21309181

Related Literature

Article Analysis
・Side Effects of saquinavir
SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.